Natus Medical urges investors not to vote for removal of Chairman Gunst
The Board of Directors of Natus Medical mailed a letter to shareholders as a reminder to shareholders regarding the importance of their vote at next week's Annual Meeting of Stockholders. The company also commented on a report from Glass Lewis & Co. regarding Natus's Annual Meeting: In its report, Glass Lewis acknowledged that "[Voce] has not presented a detailed operating plan for the Company, nor has it offered specific suggestions to improve the Company's financial or operating performance."Natus said that "While we agree with Glass Lewis in rejecting Voce's proposal to remove and replace the Chairman of the Natus Board, therefore rejecting Voce's attempt to take control of the Natus Board, we believe Glass Lewis should also have recommended that shareholders vote on the WHITE proxy card in support of Doris Engibous and Robert Weiss.This is a critical moment for Natus. The Company has developed from a small, single product company into a leader in three major markets - and we see a clear path to the next phase of growth and value creation. The Natus Board urges shareholders to vote the WHITE proxy card today FOR the election of Doris Engibous and Robert Weiss. The Natus Board recommends that shareholders not vote for the removal of Chairman Robert Gunst."